'robot suicide',[SOON MURDER BY ROBOT NEWS]


Robot kills itself over tedious household chores!


Robot kills itself over tedious household chores!
LONDON: In what is being touted as the world's first case of 'robot suicide', a house bot fed up of its tedious job of cleaning has ended its life by climbing onto a kitchen hotplate and destroying itself in a blaze.
The android in an Austrian household had to clean up some spilt cereal when it climbed onto a kitchen hotplate and was destroyed.
It had grown tired of being forced to clean the same house every day, according to reports in Austria.
"Somehow it seems to have reactivated itself and made its way along the work surface where it pushed a cooking pot out of the way and basically that was the end of it," explained fireman Helmut Kniewasser, who was called to tackle the blaze at Hinterstoder in Kirchdorf, Austria.
"It pretty quickly started to melt underneath and then stuck to the kitchen hotplate. It then caught fire. By the time we arrived, it was just a pile of ash," Kniewasser said.
The entire building had to be evacuated and there was severe smoke damage particularly in the flat where the robot had been in use, 'metro.co.uk' reported.
"It's a mystery how it came to be activated and ended up making its way to the hotplate. I don't know about the allegations of a robot suicide but the homeowner is insistent that the device was switched off," Kniewasser said.
The homeowner plans to sue the robot's manufacturer.

New drug combo causes cancer cells to 'eat themselves'


WASHINGTON: A new drug combination therapy could effectively kill colon, liver, lung, kidney, breast and brain cancer cells without affecting the healthy cells, scientists say.

The results from a recent preclinical study at Virginia Commonwealth University Massey Cancer Center lays the foundation to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.

"It is still too premature to estimate when a clinical trial will open to further test this drug combination therapy, but we are now in the planning phase and encouraged by the results of these laboratory experiments," said Andrew Poklepovic, assistant professor in the Division of Hematology, Oncology and Palliative Care at VCU School of Medicine.

The study led by Paul Dent demonstrated that the drugs sorafenib and regorafenib synergise with a class of drugs known as PI3K/AKT inhibitors to kill a variety of cancers.

Sorafenib and regorafenib work by blocking the production of enzymes called kinases, which are vital to the growth and survival of cancer cells.

Sorafenib is currently approved by the FDA to treat kidney and liver cancers, and regorafenib is currently approved for the treatment of colorectal cancer.

However, sorafenib and regorafenib do not directly affect PI3K and AKT kinases, which are also very active in promoting cancer cell survival.

The addition of a PI3K/AKT inhibitor to the combination of sorafenib and regorafenib dramatically increased cell death and was even effective against cells with certain mutations that make one or the other drug less effective.

"We know that there are certain cellular processes that are frequently dysregulated in cancers and important to cell proliferation and survival, but if you shut down one, then cells can often compensate by relying on another," said Dent.

"We are blocking several of these survival pathways, and the cancer cells are literally digesting themselves in an effort to stay alive," Dent said.

Results showed that the combination therapy killed the cells by physically interacting with molecules to block the survival pathways and induce a toxic effect known as autophagy.

Autophagy is a protective process where cells metabolise themselves when starved of the resources needed to survive.

The study was published in the journal Molecular Pharmacology.

sight is really as much a function of our brains as our eyes,RELATED People born blind can see during a near-death experience


Brain can 'see' in the dark: Study


Brain can 'see' in the dark: Study
At least 50 per cent of people can see the movement of their own hand even when it is pitch dark, a new study said.

RELATED

 

People born blind can see during a near-death experience

www.near-death.com/experiences/evidence03.html
 
 
Yet, she appears to have been able to see during her NDE. ... roof of the building itself, during which time she had a brief panoramic view of her surroundings.
WASHINGTON: At least 50 per cent of people can see the movement of their own hand even when it is pitch dark, a new study, that used computerised eye-trackers, has found.


Even in the absence of all light, the brain keeps track of the body, researchers said.

Neuroscientists and psychologists discovered that the mind continues to perceive motion in complete darkness. Their findings suggest that 50 per cent of the population sees in the dark without realising it.

"Seeing in total darkness? According to the current understanding of natural vision, that just doesn't happen," says Duje Tadin, a professor of brain and cognitive sciences at the University of Rochester who led the investigation.

"But this research shows that our own movements transmit sensory signals that also can create real visual perceptions in the brain, even in the complete absence of optical input," said Tadin.

Through five separate experiments involving 129 individuals, the authors found that this eerie ability to see our hand in the dark suggests that our brain combines information from different senses to create our perceptions.

The ability also "underscores that what we normally perceive of as sight is really as much a function of our brains as our eyes," said first author Kevin Dieter, a post-doctoral fellow in psychology at Vanderbilt University.

For most people, this ability to see self-motion in darkness probably is learned, the authors conclude.

"We get such reliable exposure to the sight of our own hand moving that our brains learn to predict the expected moving image even without actual visual input," said Dieter.

The study was published in journal Psychological Science.